For: | Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg 2023; 15(4): 495-519 [PMID: 37206081 DOI: 10.4240/wjgs.v15.i4.495] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v15/i4/495.htm |
Number | Citing Articles |
1 |
Mary Garvey. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation. Biomedicines 2024; 12(4): 740 doi: 10.3390/biomedicines12040740
|
2 |
Purvish M Parikh, Tarini P. Sahoo, Ghanashyam Biswas, Vineet Talwar, Somashekhar SP, Soumya Surath Panda, Avinash CB, Nishita Shetty, Anita Ramesh, Joydeep Ghosh, Vijith Vital Shetty, Radheshyam Naik, Ashish Singh, Gaurav Gupta, Bhavesh Parekh. Practical Consensus Guidelines for the Use of S-1 in GI Malignancies. South Asian Journal of Cancer 2024; 13(01): 077 doi: 10.1055/s-0043-1778685
|
3 |
Anil Kumar, Lekha Saha. Colorectal cancer cell dormancy: An insight into pathways. World Journal of Gastroenterology 2024; 30(33): 3810-3817 doi: 10.3748/wjg.v30.i33.3810
|
4 |
Alessandra Verdina, Alessia Garufi, Valerio D’Orazi, Gabriella D’Orazi. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to Therapies. International Journal of Molecular Sciences 2024; 25(14): 7678 doi: 10.3390/ijms25147678
|
5 |
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy. Cancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
|
6 |
Pablo Garrido, Adrián Casas-Benito, Ignacio M. Larrayoz, Judit Narro-Íñiguez, Susana Rubio-Mediavilla, Enrique Zozaya, Alfonso Martín-Carnicero, Alfredo Martínez. Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer. Cancers 2024; 16(5): 960 doi: 10.3390/cancers16050960
|
7 |
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, Morteza Aghajanpoor-Pasha, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Ahmad Rezazadeh-Mafi, Mostafa Rezaei-Tavirani, Arsalan Irompour. Cell Biology and Translational Medicine, Volume 22. Advances in Experimental Medicine and Biology 2024; 1470: 115 doi: 10.1007/5584_2024_803
|
8 |
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241255651
|
9 |
Taha I. Huda, Diep Nguyen, Arpan Sahoo, Joanna J. Song, Alexander F. Gutierrez, Boris I. Chobrutskiy, George Blanck. Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor Timelapse. Clinical Colorectal Cancer 2024; doi: 10.1016/j.clcc.2024.07.002
|
10 |
Barbara A Abreu Lopez, Rafael Pinto-Colmenarez, Fides Myles C Caliwag, Lorraine Ponce-Lujan, Mariela D Fermin, Ana V Granillo Cortés, Anette G Mejía Martínez, Ismael G Zepeda Martinez, Fernanda Gress León. Colorectal Cancer Screening and Management in Low- and Middle-Income Countries and High-Income Countries: A Narrative Review. Cureus 2024; doi: 10.7759/cureus.70933
|
11 |
Maguie El Boustani, Nayla Mouawad, Monah Abou Alezz. AP3M2: A key regulator from the nervous system modulates autophagy in colorectal cancer. Tissue and Cell 2024; 91: 102593 doi: 10.1016/j.tice.2024.102593
|
12 |
Dawid Przystupski, Dagmara Baczyńska, Joanna Rossowska, Julita Kulbacka, Marek Ussowicz. Calcium ion delivery by microbubble-assisted sonoporation stimulates cell death in human gastrointestinal cancer cells. Biomedicine & Pharmacotherapy 2024; 179: 117339 doi: 10.1016/j.biopha.2024.117339
|
13 |
Hendra Susanto, Sa'diyatul Rizqie Amaliyah Firdaus, Moch Sholeh, Agustina Tri Endharti, Ahmad Taufiq, Nik Ahmad Nizam Nik Malek, Happy Kurnia Permatasari. Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells. Journal of Agriculture and Food Research 2024; 16: 101149 doi: 10.1016/j.jafr.2024.101149
|
14 |
Anil Kumar, Bakr Ahmed, Indu Pal Kaur, Lekha Saha. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysis. International Journal of Biological Macromolecules 2024; 277: 133984 doi: 10.1016/j.ijbiomac.2024.133984
|
15 |
Otilia Menyhart, János Tibor Fekete, Balázs Győrffy. Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI). International Journal of Molecular Sciences 2024; 25(15): 8441 doi: 10.3390/ijms25158441
|
16 |
Pengju Yao, Mingjie Gao, Weiyi Hu, Jiahao Wang, Yuhao Wang, Qingsong Wang, Jianguo Ji. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer. Pharmacological Research 2024; 204: 107209 doi: 10.1016/j.phrs.2024.107209
|
17 |
Sourik Mukherjee, Dharmender Kumar, Dipanjan Guha. Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applications. Medicine in Microecology 2024; 22: 100111 doi: 10.1016/j.medmic.2024.100111
|
18 |
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
|
19 |
涵静 丁. Recent Advancements on the Anti-Tumor Small Molecule Inhibitors Targeting the p53-MDM2 Interaction. Advances in Clinical Medicine 2023; 13(08): 13474 doi: 10.12677/ACM.2023.1381881
|
20 |
Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara, Natalie Leys, Samir Kumar-Singh, Surbhi Malhotra-Kumar, Rob Van Houdt. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1298264
|
21 |
Huwei Nie, Jie Zhang, Yang Ai, Ailin Chen, Yuxi Li, Lin Zhang. Development and validation of prognostic nomograms for overall survival in patients with locally advanced colorectal cancer. Alexandria Engineering Journal 2024; 87: 308 doi: 10.1016/j.aej.2023.12.040
|
22 |
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, Joe Youssef, Chrystelle Chemaly, Samer Doughan, Wassim Abou-Kheir. Colorectal cancer: Recent advances in management and treatment. World Journal of Clinical Oncology 2024; 15(9): 1136-1156 doi: 10.5306/wjco.v15.i9.1136
|
23 |
Riley M. Whalen, Ashley N. Anderson, Jocelyn A. Jones, Zachary Sims, Young Hwan Chang, Michel A. Nederlof, Melissa H. Wong, Summer L. Gibbs. Ultra high content analyses of circulating and tumor associated hybrid cells reveal phenotypic heterogeneity. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57381-8
|
24 |
Sushma S. Kumar, Ashna Fathima, Preeti Srihari, Trinath Jamma. Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1392565
|
25 |
Bin Jiang, Hongjian Zhou, Xingwang Xie, Tian Xia, Chao Ke. Down-regulation of zinc finger protein 335 undermines natural killer cell function in mouse colitis-associated colorectal carcinoma. Heliyon 2024; 10(4): e25721 doi: 10.1016/j.heliyon.2024.e25721
|
26 |
Luis A. Arteaga-Blanco, Andrew E. Evans, Dan A. Dixon. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway. Cells 2024; 13(14): 1195 doi: 10.3390/cells13141195
|
27 |
Yiping Zhang, Jun Xie. Targeting ferroptosis regulators by natural products in colorectal cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1374722
|
28 |
Sara Assi, Berthe Hayar, Claudio Pisano, Nadine Darwiche, Walid Saad. Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted Mice. Nanomaterials 2024; 14(17): 1380 doi: 10.3390/nano14171380
|
29 |
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International Journal of Molecular Sciences 2024; 25(13): 7131 doi: 10.3390/ijms25137131
|
30 |
Marcel Madej, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Agnieszka Synowiec-Wojtarowicz, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka, Stanisław Głuszek, Jolanta Adamska, Sebastian Kubica, Jarosław Matykiewicz, Joanna Magdalena Gola. The Influence of Betulin and Its Derivatives on Selected Colorectal Cancer Cell Lines’ Viability and Their Antioxidant Systems. Cells 2024; 13(16): 1368 doi: 10.3390/cells13161368
|
31 |
Francesco Gervasi, Fanny Pojero. Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine. Biomedicines 2024; 12(3): 502 doi: 10.3390/biomedicines12030502
|
32 |
Nikola Radenković, Danijela Nikodijević, Jovana Jovankić, Stefan Blagojević, Milena Milutinović. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells. European Journal of Pharmacology 2024; 983: 176979 doi: 10.1016/j.ejphar.2024.176979
|
33 |
Marcel Madej, Joanna Gola, Elwira Chrobak. Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal Cancers. Pharmaceutics 2023; 15(12): 2768 doi: 10.3390/pharmaceutics15122768
|
34 |
Duogang Xu, Yulei He, Changkang Liao, Jing Tan. Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study. Biomedical Reports 2024; 20(6) doi: 10.3892/br.2024.1784
|
35 |
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated review. International Immunopharmacology 2024; 143: 113325 doi: 10.1016/j.intimp.2024.113325
|
36 |
Shiliang Cheng, Meng Li, Chunguang Li, Yonggang Dai, Jinhua Zhuo, Jue Wang, Jingrong Qian, Zhihao Hao. JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment. In Vitro Cellular & Developmental Biology - Animal 2024; 60(4): 382 doi: 10.1007/s11626-024-00881-8
|
37 |
Maxim Girod, Anja Geisler, Luisa Hinze, Leslie Elsner, Babette Dieringer, Antje Beling, Jens Kurreck, Henry Fechner. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. International Journal of Molecular Sciences 2024; 25(11): 5618 doi: 10.3390/ijms25115618
|
38 |
Irene Palenca, Silvia Basili Franzin, Aurora Zilli, Luisa Seguella, Anna Troiani, Federico Pepi, Martina Vincenzi, Giuseppe Giugliano, Viviana Catapano, Italia Di Filippo, Giovanni Sarnelli, Giuseppe Esposito. N‐palmitoyl‐d‐glucosamine limits mucosal damage and VEGF‐mediated angiogenesis by PPARα‐dependent suppression of pAkt/mTOR/HIF1α pathway and increase in PEA levels in AOM/DSS colorectal carcinoma in mice. Phytotherapy Research 2024; doi: 10.1002/ptr.8303
|
39 |
Ashok Kumar, Anirudh Goyal. Emerging molecules, tools, technology, and future of surgical knife in gastroenterology. World Journal of Gastrointestinal Surgery 2024; 16(4): 988-998 doi: 10.4240/wjgs.v16.i4.988
|
40 |
Chiugo Okoye, My Tran, Elizabeth Soladoye, Darlington E Akahara, Chinemerem M Emeasoba, Blessing T Ojinna, Emmanuel Anasonye, Oyindamola O Obadare, Chiamaka S Diala, Bolanle H Salaudeen, Endurance O Evbayekha, Okelue E Okobi. A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. Cureus 2023; doi: 10.7759/cureus.43189
|
41 |
Sezgin Zeren, Semih Seker, Gizem Akkaş Akgün, Emrah Okur, Azmi Yerlikaya. Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa. Medical Oncology 2023; 40(10) doi: 10.1007/s12032-023-02173-9
|
42 |
Raza M. Mirza, Sabrin Salim, Jennifer A. H. Bell, Mary Jane Esplen, Karen V. MacDonald, Barry D. Stein, Deborah A. Marshall. Exploring How Values of Colorectal Cancer Patients and their Caregivers Influence Treatment Decision-Making. The Patient - Patient-Centered Outcomes Research 2024; doi: 10.1007/s40271-024-00716-4
|
43 |
Jae Yeon Choi, Hyun Jeong Seok, Dong Hyeon Lee, Junhye Kwon, Ui Sup Shin, Incheol Shin, In Hwa Bae. miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05797-1
|
44 |
Claudia C. Wahoski, Bhuminder Singh. The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance. Cancers 2024; 16(13): 2472 doi: 10.3390/cancers16132472
|
45 |
Mariana Melo Moreira, Marta Carriço, Manuel Luís Capelas, Nuno Pimenta, Teresa Santos, Susana Ganhão-Arranhado, Antti Mäkitie, Paula Ravasco. The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395966
|